DRI Healthcare Trust
DHTRF
$8.02
-$0.0224-0.28%
| Weiss Ratings | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | C | |||
| Rating Factors | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.28% | |||
| 30-Day Total Return | -2.59% | |||
| 60-Day Total Return | -1.49% | |||
| 90-Day Total Return | -14.63% | |||
| Year to Date Total Return | -1.49% | |||
| 1-Year Total Return | -28.09% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -34.52% | |||
| 52-Week Low % Change | 4.77% | |||
| Price | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $12.40 | |||
| 52-Week Low Price | $7.75 | |||
| 52-Week Low Price (Date) | Jul 08, 2024 | |||
| 52-Week High Price (Date) | Apr 16, 2024 | |||
| Valuation | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 446.22M | |||
| Enterprise Value | 838.01M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.06 | |||
| Earnings Per Share Growth | -102.68% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.46 | |||
| Price/Book (Q) | 0.87 | |||
| Enterprise Value/Revenue (TTM) | 4.53 | |||
| Price | $8.02 | |||
| Enterprise Value/EBITDA (TTM) | 5.67 | |||
| Enterprise Value/EBIT | 18.18 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 56.68M | |||
| Dividend Yield | 4.37% | |||
| Div. Per Share (Most Recent) | $0.10 | |||
| Dividend Per Share (TTM) | $0.36 | |||
| Payout Ratio (TTM) | -1,112.15% | |||
| Dividend Per Share (Most Recent) | $0.10 | |||
| Company Info | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416-863-1865 | |||
| Address | 100 King Street West Toronto, ON M5X 1B1 | |||
| Website | www.dricapital.com | |||
| Country | Canada | |||
| Year Founded | 2020 | |||
| Profitability | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 24.90% | |||
| Profit Margin | -1.61% | |||
| Management Effectiveness | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.20% | |||
| Return on Equity | -- | |||
| Income Statement | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 184.71M | |||
| Total Revenue (TTM) | 186.99M | |||
| Revenue Per Share | $3.30 | |||
| Gross Profit (TTM) | 186.99M | |||
| EBITDA (TTM) | 149.44M | |||
| EBIT (TTM) | 46.57M | |||
| Net Income (TTM) | -3.02M | |||
| Net Income Avl. to Common (TTM) | -3.02M | |||
| Total Revenue Growth (Q YOY) | -18.57% | |||
| Earnings Growth (Q YOY) | -68.07% | |||
| EPS Diluted (TTM) | -0.06 | |||
| EPS Diluted Growth (Q YOY) | -69.30% | |||
| Balance Sheet | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 36.50M | |||
| Cash Per Share (Q) | $0.64 | |||
| Total Current Assets (Q) | 99.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 527.53M | |||
| Current Ratio (Q) | 1.211 | |||
| Book Value Per Share (Q) | $9.37 | |||
| Total Assets (Q) | 984.87M | |||
| Total Current Liabilities (Q) | 81.87M | |||
| Total Debt (Q) | 432.12M | |||
| Total Liabilities (Q) | 457.34M | |||
| Total Common Equity (Q) | 527.53M | |||
| Cash Flow | DHTRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -293.31M | |||
| Cash from Financing (TTM) | 111.56M | |||
| Net Change in Cash (TTM) | -26.33M | |||
| Levered Free Cash Flow (TTM) | -171.41M | |||
| Cash from Operations (TTM) | 155.41M | |||
